FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Fougera Pharmaceuticals Triamcinolone Acetonide Cream Recall

Triamcinolone Acetonide Cream USP, 0

Fougera Pharmaceuticals Inc. · Melville, NY

Risk level
Class III
Reported by FDA
Mar 19, 2014
Recall ID
D-1152-2014
Check your lot numberHow we source this data

Summary

Fougera Pharmaceuticals recalled Triamcinolone Acetonide Cream starting Jan 29, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1152-2014 on Mar 19, 2014. Reason: Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%. Status: Terminated.

Why it was recalled

Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.

Product description

Triamcinolone Acetonide Cream USP, 0.1%, Net Wt 80 grams per tube, Rx only, E. Fougera & Co., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0004-80, UPC 3 0168-0004-80 8.

Lot numbers, UPCs & expiration codes

Lot #: 485P, 486P, 487P, 488P, Exp 06/15; 638P, 639P, 640P, Exp 07/15; 753P, 754P, 755P, Exp 08/15; 898P, 756P, 757P, 758P, 899P, 900P, 901P, 902P, Exp 09/15

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1152-2014
Classification
Class III
Status
Terminated
Recall initiated
Jan 29, 2014
FDA report date
Mar 19, 2014
Quantity
493,192 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Fougera Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-1152-2014, exactly as published.

Show all FDA fields
City
Melville
State
NY
Status
Terminated
Country
United States
Event ID
67329
Address
60 Baylis Rd
Code information
Lot #: 485P, 486P, 487P, 488P, Exp 06/15; 638P, 639P, 640P, Exp 07/15; 753P, 754P, 755P, Exp 08/15; 898P, 756P, 757P, 758P, 899P, 900P, 901P, 902P, Exp 09/15
Postal code
11747-3838
Report date
Mar 19, 2014
Product type
Drugs
Recall number
D-1152-2014
Classification
Class III
Recalling firm
Fougera Pharmaceuticals Inc.
Product quantity
493,192 tubes
Termination date
Dec 8, 2015
Reason for recall
Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Triamcinolone Acetonide Cream USP, 0.1%, Net Wt 80 grams per tube, Rx only, E. Fougera & Co., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0004-80, UPC 3 0168-0004-80 8.
Distribution pattern
Nationwide.
Recall initiation date
Jan 29, 2014
Initial firm notification
Letter
Center classification date
Mar 7, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1152-2014, published Mar 19, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls